Loading clinical trials...
Loading clinical trials...
Randomized, Open-Label, Multiple-Dose Study to Evaluate the Effect of Omeprazole 20 mg on the Pharmacokinetics of Atazanavir Administered With Ritonavir in Healthy Subjects
The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to atazanavir or atazanavir/ritonavir in the absence of omeprazole in healthy subjects.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Local Institution
Hamilton, New Jersey, United States
Start Date
June 1, 2006
Primary Completion Date
August 1, 2006
Completion Date
August 1, 2006
Last Updated
April 8, 2011
56
Estimated participants
Atazanavir
DRUG
Atazanavir/Ritonavir
DRUG
Atazanavir/Ritonavir+Omeprazole
DRUG
Atazanavir/Ritonavir+Omeprazole
DRUG
Atazanavir
DRUG
Atazanavir/Ritonavir
DRUG
Atazanavir/Ritonavir+Omeprazole
DRUG
Atazanavir/Ritonavir+Omeprazole
DRUG
Lead Sponsor
Bristol-Myers Squibb
NCT04142047
NCT06694805
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330